Manzamine A (Synonyms: Keramamine A)

目录号: HY-117025: FAQs
Data Sheet 产品使用指南

摩尔计算器

Manzamine A 是一种口服活性 β-carboline 生物碱，抑制 GSK-3β 和 CDK-5 的 IC₅₀ 值为 10.2 μM 和 1.5 μM。Manzamine A 靶向胰腺癌细胞的 vacuolar ATPases 并抑制自噬 (autophagy)。Manzamine A 具有抗疟和抗癌活性。Manzamine A 对 HSV-1 具有较强的活性。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Manzamine A Chemical Structure

CAS No. : 104196-68-1

1. 客户无需承担相应的运输费用。

2. 同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

可免费申领三个不同产品的试用装。

3. 试用装只面向终端客户。

规格	价格	是否有货
1 mg	￥5220	3 - 4 周
5 mg		询价
10 mg		询价

or 大包装询价

* Please select Quantity before adding items.

Customer Review

Other Forms of Manzamine A:

Manzamine A hydrochloride In-stock

MCE 顾客使用本产品发表的 1 篇科研文献

•Mar Drugs. 2023, 21(3), 151.

Cell Viability Assay

Proliferation Assay

: Manzamine A purchased from MCE. Usage Cited in: Mar Drugs. 2023, 21(3), 151.; Manzamine A (MA) shows a long-term ability to inhibit both MCF-7 and MDA-MB-231 cells growth. The MA (0, 2, 4 μM; 24 h)-treated cells are seeded in 6-well plates and then cultured for 2 weeks.

: Manzamine A purchased from MCE. Usage Cited in: Mar Drugs. 2023, 21(3), 151.; Manzamine A (MA; 0, 0.5, 1, 2, 4, 8 μM; 24 h) shows cytotoxic effects on MDA-MB-231 and MCF-7 cells but is non-toxic to normal breast epithelial MCF-10A cells in a dose-dependent manner.

Manzamine A 相关产品

•同靶点产品:

•同靶点蛋白产品:

查看 GSK-3 亚型特异性产品:

查看所有亚型

GSK-3 GSK-3α GSK-3β

查看 CDK 亚型特异性产品:

查看所有亚型

CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85

查看 Parasite 亚型特异性产品:

查看所有亚型

Amebae Coccidia Leishmania Mite Plasmodium Toxoplasma Trypanosoma Schistosome

查看 HSV 亚型特异性产品:

查看所有亚型

HSV-1 HSV-2 HSV

生物活性
纯度 & 产品资料
参考文献

生物活性

Manzamine A, an orally active beta-carboline alkaloid, inhibits specifically GSK-3β and CDK-5 with IC₅₀s of 10.2 μM and 1.5 μM, respectively. Manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells. Manzamine A has antimalarial and anticancer activities. Manzamine A also shows potent activity against HSV-1^[1]^[2]^[3]^[4].

IC₅₀ & Target^[1]^[2]^[3]

Plasmodium

GSK-3β

10.2 μM (IC₅₀)

CDK5

1.5 μM (IC₅₀)

vacuolar ATPases

Malaria

HSV-1

细胞效力
(Cellular Effect)

Cell Line	Type	Value	Description	References
A549	IC₅₀	1.3 μg/mL Compound: manzamine A	Cytotoxicity against human A549 cells after 48 hrs by MTT assay Cytotoxicity against human A549 cells after 48 hrs by MTT assay	[PMID: 8350092]
A549	IC₅₀	2.3 μM Compound: 3	Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay	[PMID: 27650927]
A549	IC₅₀	5.8 μM Compound: Manzamine A	Cytotoxicity against human A549 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay Cytotoxicity against human A549 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay	[PMID: 34536668]
C-33-A	IC₅₀	1.6 μM Compound: 1	Antiproliferative activity against human C33A cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay Antiproliferative activity against human C33A cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay	[PMID: 32022559]
C-33-A	IC₅₀	2.1 μM Compound: 1	Antiproliferative activity against human C33A cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay Antiproliferative activity against human C33A cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay	[PMID: 32022559]
C-33-A	IC₅₀	5.2 μM Compound: 1	Antiproliferative activity against human C33A cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay Antiproliferative activity against human C33A cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay	[PMID: 32022559]
Ca-Ski	IC₅₀	19.9 μM Compound: 1	Antiproliferative activity against human CaSki cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay Antiproliferative activity against human CaSki cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay	[PMID: 32022559]
Ca-Ski	IC₅₀	33.6 μM Compound: 1	Antiproliferative activity against human CaSki cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay Antiproliferative activity against human CaSki cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay	[PMID: 32022559]
Ca-Ski	IC₅₀	9.4 μM Compound: 1	Antiproliferative activity against human CaSki cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay Antiproliferative activity against human CaSki cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay	[PMID: 32022559]
CHO	IC₅₀	4.8 μM Compound: 1	Non-competitive inhibition of human microsomal ACAT2 overexpressed in CHO cells using [14C]oleoyl-CoA as substrate assessed as formation of cholesteryl [14C]-oleate after 24 hrs Non-competitive inhibition of human microsomal ACAT2 overexpressed in CHO cells using [14C]oleoyl-CoA as substrate assessed as formation of cholesteryl [14C]-oleate after 24 hrs	[PMID: 23665143]
CHO	IC₅₀	6.2 μM Compound: 1	Non-competitive inhibition of human microsomal ACAT1 overexpressed in CHO cells using [14C]oleoyl-CoA as substrate assessed as formation of cholesteryl [14C]-oleate after 24 hrs Non-competitive inhibition of human microsomal ACAT1 overexpressed in CHO cells using [14C]oleoyl-CoA as substrate assessed as formation of cholesteryl [14C]-oleate after 24 hrs	[PMID: 23665143]
HeLa	IC₅₀	11.8 μM Compound: 1	Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay	[PMID: 32022559]
HeLa	IC₅₀	13 μM Compound: 1	Cytotoxicity against human HeLa cells after 3 days by MTT assay Cytotoxicity against human HeLa cells after 3 days by MTT assay	[PMID: 24902064]
HeLa	IC₅₀	4 μM Compound: 1	Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay	[PMID: 32022559]
HeLa	IC₅₀	5.3 μM Compound: 1	Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay	[PMID: 32022559]
HT-29	IC₅₀	0.8 μg/mL Compound: manzamine A	Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay	[PMID: 8350092]
IMR-90	IC₅₀	6.8 μM Compound: 3	Cytotoxicity against human IMR90 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay Cytotoxicity against human IMR90 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay	[PMID: 27650927]
K562	IC₅₀	5.2 μM Compound: Manzamine A	Cytotoxicity against human K562 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay Cytotoxicity against human K562 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay	[PMID: 34536668]
L5178Y	ED₅₀	1.8 μg/mL Compound: 7	Cytotoxicity against mouse L5178Y cells after 72 hrs by MTT assay Cytotoxicity against mouse L5178Y cells after 72 hrs by MTT assay	[PMID: 8946747]
Microglia	IC₅₀	< 0.1 μM Compound: 1	Antineuroinflammatory activity in LPS-stimulated rat neonatal microglia assessed as inhibition of PMA-induced TXB2 production preincubated 15 mins prior to PMA challenge measured after 70 mins Antineuroinflammatory activity in LPS-stimulated rat neonatal microglia assessed as inhibition of PMA-induced TXB2 production preincubated 15 mins prior to PMA challenge measured after 70 mins	[PMID: 20017491]
Microglia	IC₅₀	0.1 μM Compound: 1	Antineuroinflammatory activity in LPS-stimulated rat neonatal microglia assessed as inhibition of PMA-induced superoxide anion production preincubated 15 mins prior to PMA challenge measured after 70 mins Antineuroinflammatory activity in LPS-stimulated rat neonatal microglia assessed as inhibition of PMA-induced superoxide anion production preincubated 15 mins prior to PMA challenge measured after 70 mins	[PMID: 20017491]
NCI-H1299	IC₅₀	1.5 μM Compound: 3	Cytotoxicity against human NCI-H1299 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay Cytotoxicity against human NCI-H1299 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay	[PMID: 27650927]
NCI-H1373	IC₅₀	2.1 μM Compound: 3	Cytotoxicity against human NCI-H1373 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay Cytotoxicity against human NCI-H1373 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay	[PMID: 27650927]
NCI-H1993	IC₅₀	3.9 μM Compound: 3	Cytotoxicity against human NCI-H1993 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay Cytotoxicity against human NCI-H1993 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay	[PMID: 27650927]
NCI-H2009	IC₅₀	1.6 μM Compound: 3	Cytotoxicity against human NCI-H2009 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay Cytotoxicity against human NCI-H2009 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay	[PMID: 27650927]
NCI-H441	IC₅₀	1.1 μM Compound: 3	Cytotoxicity against human NCI-H441 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay Cytotoxicity against human NCI-H441 cells assessed as decrease in cell viability after 48 hrs by Alamar blue assay	[PMID: 27650927]
P388	IC₅₀	2.4 μg/mL Compound: manzamine A	Cytotoxicity against mouse P388 cells after 48 hrs by MTT assay Cytotoxicity against mouse P388 cells after 48 hrs by MTT assay	[PMID: 8350092]
Peritoneal macrophage cell	IC₅₀	6.2 μM Compound: 1	Antihyperlipidemic activity in apoE-deficient mouse peritoneal macrophages assessed as inhibition of acetylated LDL-induced [3H]-cholesterol ester accumulation after 24 hrs by radioscanner analysis in presence of [3H]-oleate-conjugated BSA Antihyperlipidemic activity in apoE-deficient mouse peritoneal macrophages assessed as inhibition of acetylated LDL-induced [3H]-cholesterol ester accumulation after 24 hrs by radioscanner analysis in presence of [3H]-oleate-conjugated BSA	[PMID: 23665143]
SiHa	IC₅₀	19.9 μM Compound: 1	Antiproliferative activity against human SiHa cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay Antiproliferative activity against human SiHa cells assessed as reduction in cell viability after 24 hrs by CellTiter-Glo assay	[PMID: 32022559]
SiHa	IC₅₀	4.1 μM Compound: 1	Antiproliferative activity against human SiHa cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay Antiproliferative activity against human SiHa cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay	[PMID: 32022559]
SiHa	IC₅₀	9.9 μM Compound: 1	Antiproliferative activity against human SiHa cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay Antiproliferative activity against human SiHa cells assessed as reduction in cell viability after 48 hrs by CellTiter-Glo assay	[PMID: 32022559]
Vero	IC₅₀	0.2 μg/mL Compound: 1	Cytotoxicity against african green monkey Vero cells after 48 hrs by neutral red assay Cytotoxicity against african green monkey Vero cells after 48 hrs by neutral red assay	[PMID: 20017491]
Vero	IC₅₀	0.501 μM Compound: 1	Cytotoxicity against african green monkey Vero cells after 48 hrs by neutral red assay Cytotoxicity against african green monkey Vero cells after 48 hrs by neutral red assay	[PMID: 18595720]
Vero	IC₅₀	1.2 μg/mL Compound: 1	Cytotoxicity against african green monkey Vero cells by neutral red assay Cytotoxicity against african green monkey Vero cells by neutral red assay	[PMID: 16872140]
Vero	IC₅₀	11 nM Compound: 1	Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs	[PMID: 19833520]
Vero	IC₅₀	8 nM Compound: 1	Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs	[PMID: 19833520]

体外研究
(In Vitro)

Manzamine A (5-50 µM, 18 h) decreases tau phosphorylation, measured with ELISA^[1].
Manzamine A (10 µM) inhibits yeast S. cerevisiae growth by 30%^[2].
Manzamine A displays a few enlarged vacuoles in yeast^[2].
Manzamine A (2.5-10 µM, 24 h) increases acidity in pancreatic cancer cells and non-malignant Vero cells^[2].
Manzamine A (1 µM, 24 h) inhibits HSV-1 infection in SIRC cells^[4].
Manzamine A shows antimalarial activity with an IC₅₀ of 8.0 nM (D6 clone) and 11 nM (W2 clone)^[5].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[4]

Cell Line:	SIRC cell
Concentration:	0.1, 0.5, 1, 2, 3, 5, and 10 µM
Incubation Time:	72 h
Result:	Inhibited SIRC cell viability with an IC₅₀ of 5.6 µM.

体内研究
(In Vivo)

Manzamine A (50 and 100 mol/kg, p.o. or i.p.) inhibits the growth of the rodent malaria parasite Plasmodium berghei in infected mice^[6].
Manzamine A (8 mg/kg, i.p., daily for 8 consecutive days) prolongs the survival of SW mice to 20 days^[7].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Plasmodium berghei in infected mice^[6]
Dosage:	50 or 100 mol/kg
Administration:	Intraperitoneal injection (i.p.) or oral administration (p.o.)
Result:	Inhibited the growth of the rodent malaria parasite Plasmodium berghei. Prolonged the survival of highly parasitaemic mice.

分子量

548.76

Formula

C₃₆H₄₄N₄O

CAS 号

104196-68-1

结构分类

Alkaloids

初始来源

动物

Okinawan marine sponge

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

溶解性数据

细胞实验：

DMSO 中的溶解度 : 10 mg/mL (18.22 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响，请使用新开封的 DMSO)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	1.8223 mL	9.1115 mL	18.2229 mL
5 mM	0.3645 mL	1.8223 mL	3.6446 mL
10 mM	0.1822 mL	0.9111 mL	1.8223 mL

查看完整储备液配制表

摩尔计算器
稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

浓度 _(start)

体积 _(start)

浓度 _(final)

体积 _(final)

动物溶解方案计算器

请输入动物实验的基本信息：

给药剂量

mg/kg

动物的平均体重

每只动物的给药体积

μL

动物数量

只

由于实验过程有损耗，建议您多配一只动物的量

计算结果

工作液所需浓度 : mg/mL

纯度 & 产品资料

产品使用指南 (1538 KB)

参考文献

[1]. Hamann M, et al. Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. J Nat Prod. 2007;70(9):1397-1405. [Content Brief]

[2]. Kallifatidis G, et al. The marine natural product manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells [published correction appears in Mar Drugs. 2014;12(4):2305-7]. Mar Drugs. 2013;11(9):3500-3516. Published 2013 Sep 17. [Content Brief]

[3]. Winkler JD, et al. Antimalarial activity of a new family of analogues of manzamine A. Org Lett. 2006;8(12):2591-2594. [Content Brief]

[4]. Palem JR, et al. Manzamine A as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells. Planta Med. 2011;77(1):46-51. [Content Brief]

[5]. Wahba AE, et al. Structure-activity relationship studies of manzamine A: amidation of positions 6 and 8 of the beta-carboline moiety. Bioorg Med Chem. 2009 Nov 15;17(22):7775-82. [Content Brief]

[6]. Donia M, et al. Marine natural products and their potential applications as anti-infective agents. Lancet Infect Dis. 2003 Jun;3(6):338-48. [Content Brief]

[7]. El Sayed KA, et al. New manzamine alkaloids with potent activity against infectious diseases. J Am Chem Soc. 2001 Mar 7;123(9):1804-8. [Content Brief]

Manzamine A 相关分类

完整储备液配制表

可选溶剂	浓度溶剂体积质量	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.8223 mL	9.1115 mL	18.2229 mL	45.5573 mL
	5 mM	0.3645 mL	1.8223 mL	3.6446 mL	9.1115 mL
	10 mM	0.1822 mL	0.9111 mL	1.8223 mL	4.5557 mL
	15 mM	0.1215 mL	0.6074 mL	1.2149 mL	3.0372 mL

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

产品名称：			* 需求量：
* 客户姓名：			* Email：
* 电话：			* 公司或机构名称：
留言给我们：

产品名称：			* Lot #：
* 客户姓名：			* Email：
电话：			* 部门：
* 公司或机构名称：
留言给我们：

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

Manzamine A (Synonyms: Keramamine A)

Customer Review

Other Forms of Manzamine A:

MCE 顾客使用本产品发表的 1 篇科研文献

Manzamine A 相关产品

•同靶点产品:

•同靶点蛋白产品:

查看 GSK-3 亚型特异性产品:

查看 CDK 亚型特异性产品:

查看 Parasite 亚型特异性产品:

查看 HSV 亚型特异性产品:

生物活性

纯度 & 产品资料

参考文献

摩尔计算器

稀释计算器

Manzamine A 相关分类

完整储备液配制表

Keywords:

您最近查看的产品:

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.

Manzamine A (Synonyms: Keramamine A)

Customer Review

Other Forms of Manzamine A:

Manzamine A 相关抗体

MCE 顾客使用本产品发表的 1 篇科研文献

Manzamine A 相关产品

•同靶点产品:

•同靶点蛋白产品:

查看 GSK-3 亚型特异性产品:

查看 CDK 亚型特异性产品:

查看 Parasite 亚型特异性产品:

查看 HSV 亚型特异性产品:

生物活性

纯度 & 产品资料

参考文献

Manzamine A 相关抗体:

摩尔计算器

稀释计算器

Manzamine A 相关分类

完整储备液配制表

Keywords:

您最近查看的产品:

Request for HNMR Report

Request for HNMR Report

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z